Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Red Blood Cell and Iron Disorders

December 20, 2021

A collection of features and news articles published in ASH Clinical News related to red blood cell and iron disorders.

Telemedicine Approach Helps Improve IC-Based SCD Pain Management

An approach that uses telemedicine for triage has helped patients with sickle cell disease (SCD) get infusion center (IC)-based treatment without having to go through the emergency department ...

Study Confirms Safety, Efficacy of Mitapivat to Improve Anemia, Decrease Pain Crises in Sickle Cell Disease

Sickle cell disease (SCD) affects millions of people worldwide and causes reduced quality of life (QoL), negative clinical outcomes, unpredictable pain, anemia, and shortened lifespan ...

Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH

In patients with paroxysmal nocturnal hemoglobinuria (PNH) and clinically significant extravascular hemolysis (cs-EVH), treatment with the oral factor D inhibitor danicopan plus C5 inhibitors (C5i) ravulizumab and ...

Patient Motivators Key for Participation in SCD Clinical Trials

During a poster session at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, Biree Andemariam, MD, a hematologist and founding director of the New England Sickle Cell Institute ...

Considerable Morbidity, Mortality Seen in AIHA, Making Case for Early Testing, Long-Term Study Finds

In a look at long-term observational data on the clinical features and course of disease for children with autoimmune hemolytic anemia (AIHA), patients were frequently found to have an underlying immune disorder ...

Study Validates SCD Biomarker for Targeted P-Selectin Therapy Response

In patients with sickle cell disease (SCD), assessing adhesion phenotypes using the flow adhesion of whole blood to p-selectin (FA-WB-PSel) biomarker enabled clinicians to identify biologic responders versus ...

Creatinine May Outperform Cystatin C in eGFR Calculations in SCD

Data presented at a poster session of the 66th American Society of Hematology Annual Meeting and Exposition suggest that creatinine-based equations to estimate glomerular filtration rate ...

New Therapy May Be Effective for Patients With Cold Agglutinin Disease, Warm Antibody Autoimmune Hemolytic Anemia

Pegcetacoplan increased hemoglobin (Hb) levels, reduced hemolysis, and increased FACIT-fatigue scale scores in the first weeks of treatment in patients with cold agglutinin disease (CAD) and those with warm ...

Lactated Ringer Preferred Over Normal Saline in SCD Vaso-Occlusive Episodes

Findings from a retrospective target-trial emulation study published in JAMA Internal Medicine demonstrate that balanced fluids such as lactated Ringer (LR) solution may promote better ...

CDC Guideline Results in Drop in Opioid Prescriptions for Patients with SCD

In 2016, the U.S. Centers for Disease Control and Prevention (CDC) released the Guideline for Prescribing Opioids for Chronic Pain to provide recommendations to primary care clinicians who prescribe ...

 

 

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
February 2025

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals